NovaBridge Biosciences NBP
NASDAQ NBP
$1.80 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2024)

NovaBridge Biosciences (NBP) posted quarterly Cash from Investing Activities of -$109000.0 for Q4 2024, up 99.87% quarter-over-quarter from -$81.7 million in Q3 2024.

Analysis

NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2024) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Cash from Investing Activities for 3 consecutive years, with -$109000.0 the latest figure, recorded in Q4 2024.

  • In Q4 2024, Cash from Investing Activities changed N/A year-over-year to -$109000.0; the TTM figure through Dec 2025 stood at -$81.8 million (up 28.88% YoY), while the FY2025 annual figure was $105.0 million, up 177.17% from the prior year.
  • Cash from Investing Activities rose to -$109000.0 in Q4 2024 per NBP's latest filing, from -$81.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $8.2 million in Q4 2020 and bottomed at -$81.7 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 NovaBridge Biosciences 197.68 Mn 197.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -109,000.00
Sep 30, 2024 -81.66 Mn
Dec 31, 2020 8.22 Mn
Sep 30, 2020 -41.43 Mn
Dec 31, 2019 10.97 Mn